MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berts, A.
Right arrow Articles by Minneman, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berts, A.
Right arrow Articles by Minneman, K. P.

Vol. 55, Issue 2, 296-303, February 1999

No Role for Ca++ or Protein Kinase C in Alpha-1A Adrenergic Receptor Activation of Mitogen-Activated Protein Kinase Pathways in Transfected PC12 Cells

Alf Berts, Hongying Zhong, and Kenneth P. Minneman

Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia

We studied the role of Ca++ and protein kinase C (PKC) in alpha-1A adrenergic receptor (AR)-mediated activation of mitogen-activated protein kinase pathways in PC12 cells. In PC12 cells stably transfected with the human alpha-1A AR, norepinephrine (NE) strongly activated both extracellular signal regulated kinases (ERKs) and c-jun-NH2-terminal kinases (JNK). Ten nanomolar thapsigargin (TG) increased cytoplasmic Ca++ at least as much as NE but did not activate ERKs or JNK. Higher concentrations of TG caused a small activation of ERKs but not JNK. Emptying [Ca++]i stores by pretreatment with TG prevented the NE-stimulated increase in [Ca++]i but not ERK or JNK activation. The Ca++ chelator bis(2-aminophenoxy)ethane-N-N-N'-N'-tetraacetate (BAPTA) dose dependently abolished NE-stimulated Ca++ responses but not ERK or JNK activation. NE increased tyrosine phosphorylation of Pyk2, and this response was neither blocked by BAPTA nor mimicked by TG. The phorbol ester tumor promoting agent (TPA) caused a dose-dependent activation of ERKs that was potentiated by 10 nM TG. TPA caused only a small activation of JNK relative to that caused by NE, which was not affected by TG. The potent PKC inhibitor bisindolylmaleimide I dose dependently inhibited ERK and JNK activation by TPA, but not NE. ATP and UTP activated similar mitogen-activated protein kinase responses through endogenous P2Y2 receptors, and these responses were not blocked by BAPTA or bisindolylmaleimide I, suggesting that these results may be generalizable to other Gq/11-coupled receptors. The results suggest that Ca++ release and PKC activation are neither necessary nor sufficient for alpha-1A AR-mediated activation of mitogenic responses in PC12 cells.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. P. Frazier, A. Wilson, C. J. Dougherty, H. Li, N. H. Bishopric, and K. A. Webster
PKC-{alpha} and TAK-1 are intermediates in the activation of c-Jun NH2-terminal kinase by hypoxia-reoxygenation
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1675 - H1684.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. D. Peavy, K. B. Hubbard, A. Lau, R. B. Fields, K. Xu, C. J. Lee, T. T. Lee, K. Gernert, T. J. Murphy, and J. R. Hepler
Differential Effects of Gq{alpha}, G14{alpha}, and G15{alpha} on Vascular Smooth Muscle Cell Survival and Gene Expression Profiles
Mol. Pharmacol., June 1, 2005; 67(6): 2102 - 2114.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. M. Reuben, Y. Sun, and H. S. Cheung
Basic Calcium Phosphate Crystals Activate p44/42 MAPK Signal Transduction Pathway via Protein Kinase C{micro} in Human Fibroblasts
J. Biol. Chem., August 20, 2004; 279(34): 35719 - 35725.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Lee, A. Robeva, Z. Chen, and K. P. Minneman
Mutational Uncoupling of {alpha}1A-Adrenergic Receptors from G Proteins Also Uncouples Mitogenic and Transcriptional Responses in PC12 Cells
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 471 - 477.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. C. Quinn, N. N. Johnson-Farley, J. Yoon, and D. S. Cowen
Activation of Extracellular-Regulated Kinase by 5-Hydroxytryptamine2A Receptors in PC12 Cells is Protein Kinase C-Independent and Requires Calmodulin and Tyrosine Kinases
J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 746 - 752.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Jiao, P. J. Gonzalez-Cabrera, L. Xiao, M. E. Bradley, P. W. Abel, and W. B. Jeffries
Tonic Inhibitory Role for cAMP in alpha 1a-Adrenergic Receptor Coupling to Extracellular Signal-Regulated Kinases 1/2
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 247 - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. M. Reuben, M. A. Brogley, Y. Sun, and H. S. Cheung
Molecular Mechanism of the Induction of Metalloproteinases 1 and 3 in Human Fibroblasts by Basic Calcium Phosphate Crystals. ROLE OF CALCIUM-DEPENDENT PROTEIN KINASE Calpha
J. Biol. Chem., April 19, 2002; 277(17): 15190 - 15198.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. D. Peavy, M. S. S. Chang, E. Sanders-Bush, and P. J. Conn
Metabotropic Glutamate Receptor 5-Induced Phosphorylation of Extracellular Signal-Regulated Kinase in Astrocytes Depends on Transactivation of the Epidermal Growth Factor Receptor
J. Neurosci., December 15, 2001; 21(24): 9619 - 9628.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. C. Megson, E. M. Walker, and S. J. Hill
Role of Protein Kinase Calpha in Signaling from the Histamine H1 Receptor to the Nucleus
Mol. Pharmacol., April 16, 2001; 59(5): 1012 - 1021.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
H. Zhong, T. J. Murphy, and K. P. Minneman
Activation of Signal Transducers and Activators of Transcription by alpha 1A-Adrenergic Receptor Stimulation in PC12 Cells
Mol. Pharmacol., May 1, 2000; 57(5): 961 - 967.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. Grosse, S. Roelle, A. Herrlich, J. Hohn, and T. Gudermann
Epidermal Growth Factor Receptor Tyrosine Kinase Mediates Ras Activation by Gonadotropin-releasing Hormone
J. Biol. Chem., April 14, 2000; 275(16): 12251 - 12260.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-S. Bian, W.-M. Zhang, J.-M. Pei, and T.-M. Wong
The Role of Phosphodiesterase in Mediating the Effect of Protein Kinase C on Cyclic AMP Accumulation upon kappa -Opioid Receptor Stimulation in the Rat Heart
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1065 - 1070.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
A. K. Snabaitis, H. Yokoyama, and M. Avkiran
Roles of Mitogen-Activated Protein Kinases and Protein Kinase C in {alpha}1A-Adrenoceptor-Mediated Stimulation of the Sarcolemmal Na+-H+ Exchanger
Circ. Res., February 4, 2000; 86(2): 214 - 220.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Cussac, A. Newman-Tancredi, V. Pasteau, and M. J. Millan
Human Dopamine D3 Receptors Mediate Mitogen-Activated Protein Kinase Activation Via a Phosphatidylinositol 3-Kinase and an Atypical Protein Kinase C-Dependent Mechanism
Mol. Pharmacol., November 1, 1999; 56(5): 1025 - 1030.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C.-S. Shi, S. Sinnarajah, H. Cho, T. Kozasa, and J. H. Kehrl
G13alpha -mediated PYK2 Activation. PYK2 IS A MEDIATOR OF G13alpha -INDUCED SERUM RESPONSE ELEMENT-DEPENDENT TRANSCRIPTION
J. Biol. Chem., August 4, 2000; 275(32): 24470 - 24476.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics